Search Results 1511-1520 of 18306 for Topical

1. Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). - Mayo Clinic

   Intra-nasal, inhaled, topical steroids, or local steroid injections (e.g., intra-articular injection);; Systemic corticosteroids at physiologic doses not to ...

2. Study to Evaluate the Safety, Tolerability and Antitumor Activity of Anti-B7-H3 Car-T Cell Injection (TX103) in Subjects With Recurrent or Progressive Grade 4 Glioma - Mayo Clinic

   ... topical, inhaled, or intranasal glucocorticoid therapy. Subjects with uncontrolled mental disorders, or who, in the Investigator's opinion, have a medical ...

3. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

   Use of systemic glucocorticoids (excluding topical or ophthalmic applications or inhaled forms) for more than 10 consecutive days within 90 days prior to ...

4. Seborrheic dermatitis - Symptoms and causes - Mayo Clinic

   Topical antifungals for seborrhoeic dermatitis. Cochrane Database of Systematic Reviews. 2015; doi:10.1002/14651858.CD008138.pub3. Medical review (expert ...

5. Home Remedies: Best treatment for burns - Mayo Clinic News Network

   People with severe burns often require treatment at specialized burn centers. They may need skin grafts to cover large wounds or to minimize scarring with deep ...

6. Elamipretide (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Your doctor may give you medicines (eg, topical steroid medicine, allergy medicine) to treat skin reactions. Back to top. Side Effects. Along with its needed ...

7. Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer - Mayo Clinic

   ... topical steroids, or local steroids injections (e.g., intra-articular injection); systemic corticosteroids at physiologic dose not to exceed 10 mg/day of ...

8. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   Disease is well controlled at baseline and only requiring low potency topical steroids (e.g., hydrocortisone 2.5%, hydrocortisone butyrate 0.1%, fluocinolone ...

9. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

   Note: The following uses of corticosteroids are permitted: single doses, topical applications (e.g., for rash), inhaled sprays (e.g., for obstructive ...

10. Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study - Mayo Clinic

    NOTE: Inhaled or topical steroids, and adrenal replacement steroid doses > 10 mg daily prednisone equivalent, are permitted in the absence of active autoimmune ...